5442102025-10-012025-12-315442102025-12-315442102025-10-012025-12-31CompositionOfBoardOfDirectors15442102025-12-31CompositionOfBoardOfDirectors15442102025-10-012025-12-31CompositionOfBoardOfDirectors25442102025-12-31CompositionOfBoardOfDirectors25442102025-10-012025-12-31CompositionOfBoardOfDirectors35442102025-12-31CompositionOfBoardOfDirectors35442102025-10-012025-12-31CompositionOfBoardOfDirectors45442102025-12-31CompositionOfBoardOfDirectors45442102025-10-012025-12-31CompositionOfBoardOfDirectors55442102025-12-31CompositionOfBoardOfDirectors55442102025-10-012025-12-31CompositionOfBoardOfDirectors65442102025-12-31CompositionOfBoardOfDirectors65442102025-10-012025-12-31CompositionOfBoardOfDirectors75442102025-12-31CompositionOfBoardOfDirectors75442102025-10-012025-12-31CompositionOfBoardOfDirectors85442102025-12-31CompositionOfBoardOfDirectors85442102025-10-012025-12-31CompositionOfBoardOfDirectors95442102025-12-31CompositionOfBoardOfDirectors95442102025-10-012025-12-31CompositionOfBoardOfDirectors105442102025-12-31CompositionOfBoardOfDirectors105442102025-10-012025-12-31CompositionOfCommittees145442102025-12-31CompositionOfCommittees145442102025-10-012025-12-31CompositionOfCommittees155442102025-12-31CompositionOfCommittees155442102025-10-012025-12-31CompositionOfCommittees165442102025-12-31CompositionOfCommittees165442102025-10-012025-12-31CompositionOfCommittees415442102025-12-31CompositionOfCommittees415442102025-10-012025-12-31CompositionOfCommittees425442102025-12-31CompositionOfCommittees425442102025-10-012025-12-31CompositionOfCommittees435442102025-12-31CompositionOfCommittees435442102025-10-012025-12-31CompositionOfCommittees685442102025-12-31CompositionOfCommittees685442102025-10-012025-12-31CompositionOfCommittees695442102025-12-31CompositionOfCommittees695442102025-10-012025-12-31CompositionOfCommittees705442102025-12-31CompositionOfCommittees705442102025-10-012025-12-31CompositionOfCommittees955442102025-12-31CompositionOfCommittees955442102025-10-012025-12-31CompositionOfCommittees965442102025-12-31CompositionOfCommittees965442102025-10-012025-12-31CompositionOfCommittees975442102025-12-31CompositionOfCommittees975442102025-10-012025-12-31CompositionOfCommittees985442102025-12-31CompositionOfCommittees985442102025-10-012025-12-31CompositionOfCommittees1225442102025-12-31CompositionOfCommittees1225442102025-10-012025-12-31CompositionOfCommittees1235442102025-12-31CompositionOfCommittees1235442102025-10-012025-12-31CompositionOfCommittees1245442102025-12-31CompositionOfCommittees1245442102025-12-31MeetingOfBoardOfDirectors15442102025-10-012025-12-31MeetingOfBoardOfDirectors15442102025-12-31MeetingOfBoardOfDirectors25442102025-10-012025-12-31MeetingOfBoardOfDirectors25442102025-10-012025-12-31MeetingOfCommittees15442102025-12-31MeetingOfCommittees15442102025-10-012025-12-31MeetingOfCommittees25442102025-12-31MeetingOfCommittees25442102025-10-012025-12-31MeetingOfCommittees35442102025-12-31MeetingOfCommittees35442102025-10-012025-12-31MeetingOfCommittees45442102025-12-31MeetingOfCommittees45442102025-09-305442102025-12-31UnlistedCompanyDomain15442102025-10-012025-12-31UnlistedCompanyDomain15442102025-09-30UnlistedCompanyDomain15442102025-12-31UnlistedCompanyDomain25442102025-10-012025-12-31UnlistedCompanyDomain25442102025-09-30UnlistedCompanyDomain25442102025-12-31OngoingTaxLitigationsOrDisputesDomain15442102025-12-31OngoingTaxLitigationsOrDisputesDomain25442102025-12-31OngoingTaxLitigationsOrDisputesDomain35442102025-12-31OngoingTaxLitigationsOrDisputesDomain4xbrli:pure544210EMCURENOTLISTEDINE168P01015EMCURE PHARMACEUTICALS LIMITED2025-04-012026-03-31Quarterly2025-12-31EquitytruetruetruefalseNo event has occurred, during the period October 01, 2025 to December 31, 2025, in terms of sub-para 20 of para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as per prescribed thresholdtruetrueTop 500 listed entitiestrueCOME00369OriginaltruefalseMrBerjis Minoo Desai******00153675Non-Executive - Non Independent DirectorChairperson1956-08-02falseActiveNA1997-04-032022-07-286151MrSatish Ramanlal Mehta******00118691Executive DirectorNot ApplicableCEO-MD1951-01-13falseActiveNA1981-04-162022-04-011010MrSunil Rajanikant Mehta******00118469Executive DirectorNot Applicable1963-03-23falseActiveNA2013-06-052023-06-051000MrsNamita Vikas Thapar******05318899Executive DirectorNot Applicable1977-03-21falseActiveNA2014-07-282024-07-282110MrSamit Satish Mehta******00332562Executive DirectorNot Applicable1980-04-04falseActiveNA2022-07-282022-07-281000MrMukund Keshao Gurjar******00026843Executive DirectorNot Applicable1952-08-28falseActiveNA2001-07-232025-08-281000MrPalamadai Sundararajan Jayakumar******01173236Non-Executive - Independent DirectorNot Applicable1962-04-08falseActiveNA2020-07-222023-07-2265.17773MrVijay Keshav Gokhale******09134089Non-Executive - Independent DirectorNot Applicable1959-01-24falseActiveNA2021-04-162021-04-1656.162230MrsVidya Rajiv Yeravdekar******02183179Non-Executive - Independent DirectorNot Applicable1964-06-28falseActiveNA2021-04-162021-04-1656.162220MrShailesh Kripalu Ayyangar******00268076Non-Executive - Independent DirectorNot Applicable1954-10-15falseActiveNA2023-06-022023-06-0230.32241truetruetruetruetrueAudit Committee01173236Palamadai Sundararajan JayakumarNon-Executive - Independent DirectorChairperson2020-07-22Audit Committee00153675Berjis Minoo DesaiNon-Executive - Non Independent DirectorMember2005-06-17Audit Committee09134089Vijay Keshav GokhaleNon-Executive - Independent DirectorMember2022-07-27Nomination and remuneration committee09134089Vijay Keshav GokhaleNon-Executive - Independent DirectorChairperson2022-07-27Nomination and remuneration committee01173236Palamadai Sundararajan JayakumarNon-Executive - Independent DirectorMember2021-04-16Nomination and remuneration committee00153675Berjis Minoo DesaiNon-Executive - Non Independent DirectorMember2024-12-31Stakeholders Relationship Committee00153675Berjis Minoo DesaiNon-Executive - Non Independent DirectorChairperson2011-05-07Stakeholders Relationship Committee00118691Satish Ramanlal MehtaExecutive DirectorMember2011-05-07Stakeholders Relationship Committee09134089Vijay Keshav GokhaleNon-Executive - Independent DirectorMember2022-07-27Risk Management Committee00268076Shailesh Kripalu AyyangarNon-Executive - Independent DirectorChairperson2023-06-02Risk Management Committee01173236Palamadai Sundararajan JayakumarNon-Executive - Independent DirectorMember2021-07-27Risk Management Committee09134089Vijay Keshav GokhaleNon-Executive - Independent DirectorMember2022-07-27Risk Management Committee00118469Sunil Rajanikant MehtaExecutive DirectorMember2025-06-21Corporate Social Responsibility Committee00118469Sunil Rajanikant MehtaExecutive DirectorChairperson2013-11-26Corporate Social Responsibility Committee00332562Samit Satish MehtaExecutive DirectorMember2025-06-21Corporate Social Responsibility Committee09134089Vijay Keshav GokhaleNon-Executive - Independent DirectorMember2022-07-272025-08-07true10822025-11-1195true1093Audit Committee2025-08-07true3320Audit Committee2025-11-1195true3320Nomination and remuneration committee2025-11-11true3320Risk Management Committee2025-12-18true4320truetruetruetrueYestruetruetrueTajuddin ShaikhChief Financial OfficerfalseTajuddin ShaikhChief Financial OfficerPune2026-01-2800000The Company has acquired equity share capital in Torrent Urja 37 Private Limited ("Torrent"), twice, during the quarter i.e., on 20-11-2025 and 17-12-2025 of total 24.03% of current paid-up capital. . However, the aggregate % of holding at the end of previous quarter and at the end of the current quarter remains same. Zuventus Healthcare Limited2025-10-030.87480.12521Torrent Urja 37 Private Limited2025-12-170.280300.2803Deputy Commissioner of Income tax, Central Circle 2 (1)- Pune2023-12-27The Company has received assessment orders u/s 143(3) rws 144C(3) and r.w.s 153A of the Income Tax Act, 1961, for the Financial Year 2014-15 until Financial Year 2020-21 (Assessment Year 2015-16 to Assessment Year 2021-22) for an aggregate demand of Rs. 1,828.15 million and order u/s 143(3) for Financial Year 2021-22 (Assessment Year 2022-23) for demand of Rs. 26.15 million payable on account of disallowance of certain advertisement and promotional expenses and transfer pricing adjustments made. The Company has filed appeals in relation to such orders with the Commissioner of Income Tax (Appeals).The cases are pending for disposal with Commissioner of Income Tax (Appeals).The cases are pending for disposal with Commissioner of Income Tax (Appeals).Deputy Commissioner of Income tax, Central Circle 2 (1)- Pune2022-10-22Subsidiary of Company, Zuventus Healthcare Limited (Zuventus) has received assessment orders u/s 143(3) r.w.s 153A of the Income Tax Act, 1961, for the Financial Year 2014-15 until Financial Year 2020-21 (Assessment Year 2015-16 to Assessment Year 2021-22) for an aggregate demand of Rs. 1,078.00 million and order u/s 143(3) for Financial Year 2021-22 to Financial Year 2022-23 (Assessment Year 2022-23 to 2023-24) for demand of Rs. 32.62 million payable on account of disallowances of certain advertisement and promotional expenses. Zuventus has filed appeals in relation to such orders with the Commissioner of Income Tax (Appeals). The cases are pending for disposal with Commissioner of Income Tax (Appeals).The cases are pending for disposal with Commissioner of Income Tax (Appeals).Deputy Commissioner of State Tax, LTUE604, Pune2025-09-18Show cause notice (SCN) under Section 73(1) of the CGST/ MGST Act, 2017 issued in connection with alleged misclassification in outward supply due to HSN and reconciliation of turnover based on TDS Return filed by customers. The general rate of GST on Pharmaceuticals products is @12% and some goods specified in GST Rate Notification 01/2017 are charged to GST @ 5%. The Authority has challenged 5% GST rate and issued SCN for differential rate of 7%. GST impact of issues raised in SCN is Rs. 712.83 million (including interest of Rs. 283.15 million and penalty of Rs. 66.52 million). The Company had submitted reply for the said SCN on 17-10-2025 and personal hearing was granted. Based on the personal hearing, an order has been passed on 17-12-2025. As per the Order, alleged HSN misclassification has been dropped. However, demand confirmed for difference in turnover with TDS Return filed by Customers. The revised demand is Rs. 402.14 million (including interest of Rs. 163.87 million and penalty of Rs. 21.66 million). The Company has filed application for rectification with the Authority.Deputy Commissioner of State Tax, LTU-E604, Pune2025-09-23Show cause notice (SCN) under Section 73(1) of the CGST/ MGST Act, 2017 issued in connection with alleged excess ITC claimed in GSTR-3B / 9 which are not confirmed with GST Portal in GSTR-2B and in-eligible ITC claimed from vendor whose GST number have been cancelled. GST impact of issues raised in SCN is Rs. 532.59 million (including interest of Rs. 210.65 million and penalty of Rs. 52.60 million). The Company has submitted reply for the said SCN on 20.10.2025 and personal hearing was granted. Based on the personal hearing, an order has been passed on 17-12-2025 revising the demand, which is now Rs. 112.68 million (including interest of Rs. 48.59 million and Penalty of Rs. 5.83 million).The Company will file an appeal against the order.